A comparative study of fluoxetine, moclobemide, and tianeptine in the treatment of posttraumatic stress disorder following an earthquake

European Psychiatry

Volumn 21, Issue 3, 2006, Pages 174-179

  Onder E ^a   Tural, Ü ^a   Aker, T ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Fluoxetine; Moclobemide; Natural disasters; Posttraumatic stress disorder; Tianeptine; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; MOCLOBEMIDE; TIANEPTINE;

ADULT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; AROUSAL; ARTICLE; AVOIDANCE BEHAVIOR; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; EARTHQUAKE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SEDATION; SEX DIFFERENCE; SIDE EFFECT; STATISTICAL ANALYSIS;

ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; FEMALE; FLUOXETINE; HUMANS; MALE; MOCLOBEMIDE; NATURAL DISASTERS; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC; THIAZEPINES; TIME FACTORS; TREATMENT OUTCOME; TURKEY;

EID: 33646074019     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2005.03.007     Document Type: Article

References (26)

1. Aker A.T., Özeren M., Başoǧlu M., Kaptanoǧlu C., and Erol A. Turkish validity and reliability of CAPS. Turk. Psikiyatri. Derg. 10 (1999) 286-293 [Turkish]
2. Albucher R.C., and Liberzon I. Psychopharmacological treatment in PTSD: a critical review. J. Psychiatr. Res. 36 (2002) 355-367
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed (1994), APA, Washington, DC
4. Ansseau M., Bataille M., Briole G., De Nayer A., Fauchère P.A., Ferrero F., et al. Controlled comparison of tianeptine, alprazolam and mianserin in the treatment of adjustment disorders with anxiety and depression. Hum. Psychopharmacol. 11 (1996) 293-298
5. Blake D.D., Weathers F.W., Nagy L.M., Kaloupek D.G., Klauminzer G., Charney D.S., et al. A clinician rating scale for assessing current and lifetime PTSD: the CAPS-1. Behav. Ther. 13 (1990) 187-188
6. Brunello N., Davidson J.R.T., Deahl M., Kessler R.C., Mendlewicz J., Racagni G., et al. Posttraumatic stress disorder: diagnosis and epidemiology, comorbidity and social consequences, biology and treatment. Neuropsychobiology 43 (2001) 150-162
7. Connor K.M., Sutherland S.M., Tupler L.A., Malik M.L., and Davidson J.R. Fluoxetine in posttraumatic stress disorder. Randomized, double blind study. Br. J. Psychiatry 175 (1999) 17-22
8. Conrad C.D., LeDoux J.E., Magarinos A.M., and McEwen B.S. Repeated restraint stress facilitates fear conditioning independently of causing hippocampal CA3 dendritic atrophy. Behav. Neurosci. 113 (1999) 902-913
9. Czeh B., Michaelis T., Watanabe T., Frahm J., De Biurrun G., Van Kampen M., et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl. Acad. Sci. USA 98 (2001) 12796-12801
10. Davidson J.R. Pharmacotherapy of posttraumatic stress disorder: treatment options, long-term follow-up, and predictors of outcome. J. Clin. Psychiatry 61 Suppl 5 (2000) 52-59
11. Davidson J., and Pelton S. Forms of atypical depression and their response to antidepressant drugs. Psychiatry Res. 17 (1986) 87-95
12. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). Clinical Version (1996), APA, Washington, DC
13. Frančišković T, Moro L, Lesica T, Pernar M. Tianeptine in the treatment of posttraumatic stress disorder. Poster presented at Sixth European Conference on Traumatic Stress, June 5th-8th, 1999, Istanbul, Turkey. p. 151.
14. Foa E.B., Davidson J.R.T., and Frances A. The expert consensus guideline series. Treatment of posttraumatic stress disorder. J. Clin. Psychiatry 60 Suppl 16 (1999) 4-69
15. Government Planning Organization Undersecretary of Prime Ministry of Turkish Republic. The earthquake report. Ankara: Printing Office of Prime Ministry; 1999. p. 1-127 [Turkish].
16. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville: National Institute of Mental Health, Dept of Health, Education, and Welfare publication (ADM); 1976. p. 76-338.
17. Haefely W., Burkard W.P., Cesura A.M., Kettler R., Lorez H.P., Martin J.R., et al. Biochemistry and pharmacology of moclobemide, a prototype RIMA. Psychopharmacology 196 (1992) S6-S14
18. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6 (1967) 278-296
19. Martenyi F., Brown E.B., Zhang H., Prakash A., and Koke S.C. Fluoxetine versus placebo in posttraumatic stress disorder. J. Clin. Psychiatry 63 (2002) 199-206
20. Martenyi F., Brown E.B., Zhang H., Koke S.C., and Prakash A. Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder. Br. J. Psychiatry 181 (2002) 315-320
21. Martenyi F., Dossenbach M., Mraz K., and Metcalfe S. Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile. Eur. Neuropsychopharmacol. 11 (2001) 227-232
22. Neal L.A., Shapland W., and Fox C. An open trial of moclobemide in the treatment of post-traumatic stress disorder. Int. Clin. Psychopharmacol. 12 (1997) 231-237
23. Saporta J.A., and Van der Kolk B.A. Psychobiological consequences of severe trauma. In: Başoǧlu M. (Ed). Torture and its consequences (1992), Cambridge University Press, Glasgow 151-181
24. Stahl S.M. Classical antidepressants, serotonin selective reuptake inhibitors and noradrenergic reuptake inhibitors. In: Stahl S.M. (Ed). Essential psychopharmacology. Neuroscientific basis and practical applications. 2nd ed (2000), Cambridge University Press, New York 143-199
25. Van der Kolk B.A., Dreyfuss D., Michaels M., Shera D., Berkowitz R., Fisler R., et al. Fluoxetine in posttraumatic stress disorder. J. Clin. Psychiatry 55 (1994) 517-522
26. Wagstaff A.J., Ormrod D., and Spencer C.M. Tianeptine. A review of its use in depressive disorders. CNS Drugs 15 (2001) 231-259